| An integrated surveillance study of SARS-CoV-2, influenza virus, and respiratory syncytial virus infections | CMI communications |  | | 2026 | 23 | 88 |
|
| Prevalence and factors associated with severe fatigue 2 years into the COVID-19 pandemic : a cross-sectional population-based study in Geneva, Switzerland | BMJ open |  | | 2025 | 111 | 295 |
|
| Covid-19 pandemic-related changes in teleworking, emotional exhaustion, and occupational burnout : a cross-sectional analysis of a cohort study | BMC public health |  | | 2025 | 89 | 529 |
|
| Biopsychosocial risk factors for subjective cognitive decline among older adults during the COVID-19 pandemic : a population-based study | Public health |  | | 2024 | 21 | 239 |
|
| Which trial do we need ? Randomized, placebo-controlled trial of antiviral treatment in patients hospitalized for influenza | Clinical microbiology and infection |  | | 2024 | 34 | 325 |
|
| Clinical severity of Delta and 3 different Omicron sublineages in patients hospitalized because of COVID-19 in a Swiss tertiary center | CMI communications |  | | 2024 | 69 | 158 |
|
| Mental health trajectories among the general population and higher-risk groups following the COVID-19 pandemic in Switzerland, 2021-2023 | Journal of affective disorders |  | | 2024 | 14 | 156 |
|
| Identification of a measles variant displaying mutations impacting molecular diagnostics, Geneva, Switzerland, 2023 | Euro surveillance |  | | 2024 | 80 | 192 |
|
| Ebola : d'un traitement symptomatique au déploiement de vaccins et de traitements spécifiques | |  | | 2024 | 127 | 70 |
|
| Use of complementary medicine and its association with SARS-CoV-2 vaccination during the COVID-19 pandemic : a longitudinal cohort study | Swiss medical weekly |  | | 2023 | 74 | 192 |
|
| The longitudinal study of subjective wellbeing and absenteeism of healthcare workers considering post-COVID condition and the COVID-19 pandemic toll | Scientific reports |  | | 2023 | 160 | 43 |
|
| Trends in management and outcomes of COVID patients admitted to a Swiss tertiary care hospital | Scientific reports |  | | 2023 | 211 | 161 |
|
| Hepatitis E Virus Infection Epidemiology in Recipients of Allogeneic Hematopoietic Cell Transplant | Open forum infectious diseases |  | | 2023 | 72 | 153 |
|
| Different virus, same mistakes: Why (re-) emerging viruses are one step ahead of us | The Innovation |  | | 2022 | 267 | 108 |
|
| Spécificités de l’infection à SARS-CoV-2 chez les patients âgés | Revue médicale suisse |  | | 2022 | 80 | 113 |
|
| One-year persistent symptoms and functional impairment in SARS-CoV-2 positive and negative individuals | Journal of internal medicine |  | | 2022 | 279 | 142 |
|
| Patterns of Long COVID Symptoms: A Multi-Center Cross Sectional Study | Journal of clinical medicine |  | | 2022 | 178 | 196 |
|
| Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs | Nature communications |  | | 2022 | 293 | 239 |
|
| Bas les masques, et après ? | Revue médicale suisse |  | | 2022 | 72 | 107 |
|
| The pandemic toll and post-acute sequelae of SARS-CoV-2 in healthcare workers at a Swiss University Hospital | Preventive medicine reports |  | | 2022 | 262 | 199 |
|
| Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2 | Nature medicine |  | | 2022 | 286 | 515 |
|
| The chronification of post-COVID condition associated with neurocognitive symptoms, functional impairment and increased healthcare utilization | Scientific reports |  | | 2022 | 229 | 132 |
|
| Characteristics of long-COVID among older adults: a cross-sectional study | International journal of infectious diseases |  | | 2022 | 169 | 275 |
|
| Evolution of COVID-19 mortality over time: results from the Swiss hospital surveillance system (CH-SUR) | Swiss medical weekly |  | | 2021 | 421 | 179 |
|
| Maladies infectieuses | Revue médicale suisse |  | | 2021 | 396 | 125 |
|
| Feasibility and safety of rVSV-ZEBOV vaccination of humanitarian health workers against Ebola virus disease: an observational study | Journal of travel medicine |  | | 2021 | 230 | 0 |
|
| Clinical, virological and immunological features of a mild case of SARS-CoV-2 re-infection | Clinical Microbiology and Infection |  | | 2021 | 529 | 377 |
|
| Novel SARS-CoV-2 variants: the pandemics within the pandemic | Clinical Microbiology and Infection |  | | 2021 | 280 | 603 |
|
| Puumala Virus Infection in Family, Switzerland | Emerging Infectious Diseases |  | | 2021 | 463 | 477 |
|
| Traitement du SARS-CoV-2 en pédiatrie : quelles évidences et quelle utilité ? | Revue médicale suisse |  | | 2021 | 203 | 197 |
|
| Risk of reinfection after seroconversion to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A population-based propensity-score matched cohort study | Clinical Infectious Diseases |  | | 2021 | 511 | 370 |
|
| Covid-19: a puzzle with many missing pieces | BMJ (Clinical Research Edition) |  | | 2020 | 345 | 684 |
|
| Diagnostic challenges of central nervous system infection: extensive multiplex panels versus stepwise guided approach | Clinical microbiology and infection |  | | 2020 | 103 | 401 |
|
| Diagnosis of latent tuberculosis infection is associated with reduced HIV viral load and lower risk for opportunistic infections in people living with HIV | PLoS biology |  | | 2020 | 105 | 37 |
|
| Early experimental COVID-19 therapies: associations with length of hospital stay, mortality and related costs | Swiss Medical Weekly |  | | 2020 | 515 | 545 |
|
| Clinical features of covid-19 | BMJ |  | | 2020 | 319 | 1 |
|
| Daily viral kinetics and innate and adaptive immune response assessment in COVID-19: a case series | mSphere |  | | 2020 | 526 | 240 |
|
| Dexamethasone and remdesivir: finding method in the COVID-19 madness | The Lancet microbe |  | | 2020 | 256 | 56 |
|
| Understanding the emerging coronavirus: what it means for health security and infection prevention | Journal of Hospital Infection |  | | 2020 | 263 | 215 |
|
| New filovirus disease classification and nomenclature | Nature Reviews Microbiology |  | | 2019 | 403 | 0 |
|
| Ebola Virus Shedding and Transmission: Review of Current Evidence | The Journal of Infectious Diseases |  | | 2016 | 562 | 652 |
|
| Ebola virus disease diagnosis by real-time RT-PCR: A comparative study of 11 different procedures | Journal of clinical virology |  | | 2016 | 672 | 511 |
|
| Clinical Management of Ebola Virus Disease in the United States and Europe | New England Journal of Medicine |  | | 2016 | 1,232 | 378 |
|
| Ebola Virus Disease Complications as Experienced by Survivors in Sierra Leone | Clinical infectious diseases |  | | 2016 | 647 | 519 |
|
| Sequelae of Ebola virus disease: the emergency within the emergency | The Lancet Infectious Diseases |  | | 2016 | 470 | 0 |
|
| The 2014–2015 Ebola outbreak in West Africa: Hands On | Antimicrobial Resistance and Infection Control |  | | 2016 | 550 | 277 |
|
| Ebola: le point au crépuscule d'une épidémie inattendue | Revue médicale suisse |  | | 2015 | 144 | 355 |
|
| Infectiologie en 2014: une année virale | Revue médicale suisse |  | | 2015 | 509 | 2 |
|
| Clinical features and viral kinetics in a rapidly cured patient with Ebola virus disease: a case report | Lancet. Infectious diseases |  | | 2015 | 717 | 1 |
|